|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(IRS Employer
Identification No.)
|
|
|
|
|
||
|
||
(Address of Principal Executive Offices, zip code)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
☒
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☐
|
Smaller Reporting Company
|
|
Emerging growth company
|
|
As of November 1, 2022, there were
F-1 | |
F-2 | |
F-4 | |
F-5 | |
F-6 | |
F-8 | |
F-10 | |
3 | |
17 | |
18 | |
19 | |
19 | |
19 | |
19 | |
19 | |
19 | |
20 | |
20 |
PART I. FINANCIAL INFORMATION
September 30,
2022
|
December 31,
2021
|
|||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
||||
Marketable securities
|
|
|
||||||
Trade receivables, net of allowances of $
|
|
|
||||||
Inventories, net
|
|
|
||||||
Prepaid expenses and other current assets
|
|
|
||||||
Total current assets
|
|
|
||||||
LONG-TERM ASSETS:
|
||||||||
Marketable securities
|
|
|
||||||
Deferred tax assets, net
|
|
|
||||||
Property, plant and equipment, net
|
|
|
||||||
Operating lease right-of-use assets, net
|
|
|
||||||
Intangible assets, net
|
|
|
||||||
Goodwill
|
|
|
||||||
Other long-term assets
|
|
|
||||||
Total long-term assets
|
|
|
||||||
Total assets
|
$
|
|
$
|
|
F - 2
September 30,
2022
|
December 31,
2021 |
|||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Trade payables, net
|
$
|
|
$
|
|
||||
Employees and payroll accruals
|
|
|
||||||
Warranty obligations
|
|
|
||||||
Deferred revenues and customers advances
|
|
|
||||||
Accrued expenses and other current liabilities
|
|
|
||||||
Total current liabilities
|
|
|
||||||
LONG-TERM LIABILITIES:
|
||||||||
Convertible senior notes, net
|
|
|
||||||
Warranty obligations
|
|
|
||||||
Deferred revenues
|
|
|
||||||
Finance lease liabilities
|
|
|
||||||
Operating lease liabilities
|
|
|
||||||
Other long-term liabilities
|
|
|
||||||
Total long-term liabilities
|
|
|
||||||
COMMITMENTS AND CONTINGENT LIABILITIES
|
||||||||
STOCKHOLDERS’ EQUITY:
|
||||||||
Common stock of $
|
|
|
||||||
Additional paid-in capital
|
|
|
||||||
Accumulated other comprehensive loss
|
( |
)
|
( |
)
|
||||
Retained earnings
|
|
|
||||||
Total stockholders’ equity
|
|
|
||||||
Total liabilities and stockholders’ equity
|
$
|
|
$
|
|
F - 3
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
Revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Cost of revenues
|
|
|
|
|
||||||||||||
Gross profit
|
|
|
|
|
||||||||||||
Operating expenses:
|
||||||||||||||||
Research and development
|
|
|
|
|
||||||||||||
Sales and marketing
|
|
|
|
|
||||||||||||
General and administrative
|
|
|
|
|
||||||||||||
Other operating expenses (income), net
|
(
|
) |
|
|
|
|
||||||||||
Total operating expenses
|
|
|
|
|
||||||||||||
Operating income
|
|
|
|
|
||||||||||||
Financial expense, net
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
) | ||||||||
Other income |
||||||||||||||||
Income before income taxes
|
|
|
|
|
||||||||||||
Income taxes
|
|
|
|
|
||||||||||||
Net income
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Net basic earnings per share of common stock
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Net diluted earnings per share of common stock
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Weighted average number of shares used in computing net basic earnings per share of common stock
|
|
|
|
|
||||||||||||
Weighted average number of shares used in computing net diluted earnings per share of common stock
|
|
|
|
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
F - 4
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
Net income
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Other comprehensive income (loss), net of tax:
|
||||||||||||||||
Net change related to available-for-sale securities
|
( |
)
|
|
|
( |
)
|
(
|
)
|
||||||||
Net change related to cash flow hedges
|
( |
)
|
|
( |
)
|
|
||||||||||
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment nature
|
(
|
)
|
(
|
) |
(
|
)
|
(
|
)
|
||||||||
Foreign currency translation adjustments, net
|
|
|
(
|
) |
(
|
)
|
(
|
)
|
||||||||
Total other comprehensive loss
|
( |
)
|
(
|
) |
( |
)
|
(
|
)
|
||||||||
Comprehensive income (loss)
|
$
|
( |
)
|
$
|
|
$
|
( |
)
|
$
|
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
F - 5
Common stock |
Additional |
Accumulated
other
|
||||||||||||||||||||||
Number
|
Amount
|
paid in
Capital
|
comprehensive
loss
|
Retained
earnings
|
Total
|
|||||||||||||||||||
Balance as of January 1, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||
Issuance of common stock upon exercise of stock-based awards
|
|
*
|
|
|
|
|
||||||||||||||||||
Stock based compensation
|
-
|
|
|
|
|
|
||||||||||||||||||
Issuance of common stock in a secondary public offering, net of underwriters' discounts and commissions of $
|
|
|
|
|
|
|
||||||||||||||||||
Other comprehensive loss adjustments
|
-
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
Net income
|
-
|
|
|
|
|
|
||||||||||||||||||
Balance as of March 31, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||
Issuance of Common Stock upon exercise of stock-based awards
|
|
*
|
|
|
|
|
||||||||||||||||||
Issuance of Common stock under employee stock purchase plan
|
|
*
|
|
|
|
|
||||||||||||||||||
Stock based compensation
|
-
|
|
|
|
|
|
||||||||||||||||||
Other comprehensive loss adjustments
|
-
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
Net income
|
-
|
|
|
|
|
|
||||||||||||||||||
Balance as of June 30, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||
Issuance of Common Stock upon exercise of stock-based awards |
* |
|||||||||||||||||||||||
Stock based compensation |
- | |||||||||||||||||||||||
Other comprehensive loss adjustments |
- |
( |
) |
( |
) | |||||||||||||||||||
Net income |
- |
|
|
|||||||||||||||||||||
Balance as of September 30, 2022 |
$ | $ | $ |
( |
) | $ |
|
$ |
|
F - 6
Common stock |
Additional |
Accumulated
other
|
||||||||||||||||||||||
Number
|
Amount
|
paid in
Capital
|
comprehensive
income (loss)
|
Retained
earnings
|
Total
|
|||||||||||||||||||
Balance as of January 1, 2021
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||||
Cumulative effect of adopting ASU 2020-06
|
-
|
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||||
Issuance of Common Stock upon exercise of stock-based awards
|
|
*
|
|
|
|
|
||||||||||||||||||
Stock based compensation
|
-
|
|
|
|
|
|
||||||||||||||||||
Other comprehensive loss adjustments
|
-
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
Net income
|
-
|
|
|
|
|
|
||||||||||||||||||
Balance as of March 31, 2021
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||
Issuance of Common Stock upon exercise of stock-based awards
|
|
*
|
|
|
|
|
||||||||||||||||||
Stock based compensation
|
-
|
|
|
|
|
|
||||||||||||||||||
Other comprehensive income adjustments
|
-
|
|
|
|
|
|
||||||||||||||||||
Net income
|
-
|
|
|
|
|
|||||||||||||||||||
Balance as of June 30, 2021
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||
Issuance of Common Stock upon exercise of stock-based awards |
* |
|||||||||||||||||||||||
Stock based compensation |
- | |||||||||||||||||||||||
Other comprehensive loss adjustments |
- | ( |
) | ( |
) | |||||||||||||||||||
Net income |
- | |||||||||||||||||||||||
Balance as of September 30, 2021 |
$ | $ | $ | ( |
) | $ | $ |
F - 7
Nine Months Ended
September 30, |
||||||||
2022
|
2021
|
|||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$
|
|
$
|
|
||||
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
||||||||
Depreciation of property, plant and equipment
|
|
|
||||||
Amortization of intangible assets
|
|
|
||||||
Amortization of debt discount and debt issuance costs
|
|
|
||||||
Amortization of premium and accretion of discount on available-for-sale marketable securities, net
|
|
|
||||||
Impairment of goodwill and intangible assets
|
|
|
||||||
Stock-based compensation expenses
|
|
|
||||||
Gain from sale of privately held company |
( |
) | ||||||
Deferred income taxes, net
|
( |
)
|
(
|
)
|
||||
Loss (gain) from sale and disposal of assets
|
( |
) |
|
|||||
Exchange rate fluctuations and other items, net
|
|
|
||||||
Changes in assets and liabilities:
|
||||||||
Inventories, net
|
( |
)
|
|
|||||
Prepaid expenses and other assets
|
( |
)
|
(
|
)
|
||||
Trade receivables, net
|
( |
)
|
(
|
)
|
||||
Trade payables, net
|
|
|
(
|
)
|
||||
Employees and payroll accruals
|
|
|
||||||
Warranty obligations
|
|
|
||||||
Deferred revenues and customers advances
|
|
|
||||||
Other liabilities, net
|
|
|
||||||
Net cash provided by (used in) operating activities
|
( |
)
|
|
|||||
Cash flows from investing activities:
|
||||||||
Proceed from sales and maturities of available-for-sale marketable securities
|
|
|
||||||
Purchase of property, plant and equipment
|
( |
) |
(
|
)
|
||||
Investment in available-for-sale marketable securities
|
( |
) |
(
|
)
|
||||
Investment in a privately-held company |
( |
) | ||||||
Proceeds from sale of a privately-held company
|
|
|
||||||
Withdrawal from bank deposits, net |
|
|||||||
Payment for asset acquisition, net of cash acquired |
|
( |
) | |||||
Other investing activities
|
|
|
||||||
Net cash used in investing activities
|
$
|
( |
)
|
$
|
(
|
) |
F - 8
Nine Months Ended
September 30, |
||||||||
2022
|
2021
|
|||||||
Cash flows from financing activities:
|
||||||||
Proceeds from secondary public offering, net of issuance costs
|
$
|
|
$
|
|
||||
Repayment of bank loans
|
( |
) |
(
|
)
|
||||
Proceeds from exercise of stock-based awards
|
|
|
||||||
Tax withholding in connection with stock-based awards, net
|
( |
)
|
( |
) |
||||
Other financing activities
|
( |
)
|
(
|
)
|
||||
Net cash provided by (used in) financing activities
|
|
(
|
)
|
|||||
Increase (decrease) in cash and cash equivalents
|
|
(
|
)
|
|||||
Cash and cash equivalents at the beginning of the period
|
|
|
||||||
Effect of exchange rate differences on cash and cash equivalents
|
( |
)
|
(
|
)
|
||||
Cash and cash equivalents at the end of the period
|
$
|
|
$
|
|
||||
Supplemental disclosure of non-cash activities:
|
||||||||
Right-of-use asset recognized with a corresponding lease liability
|
$
|
|
$
|
|
F - 9
a. |
SolarEdge Technologies, Inc. (the “Company”) and its subsidiaries design, develop, and sell an intelligent inverter solution designed to maximize power generation at the individual photovoltaic (“PV”) module level while lowering the cost of energy produced by the solar PV system and providing comprehensive and advanced safety features. The Company’s products consist mainly of (i) power optimizers designed to maximize energy throughput from each and every module through constant tracking of Maximum Power Point individually per module, (ii) inverters which invert direct current (DC) from the PV module to alternating current (AC) including the Company’s future ready energy hub inverter which supports, among other things, connection to a DC- coupled battery for backup capabilities, (iii) a remote cloud-based monitoring platform, that collects and processes information from the power optimizers and inverters to enable customers and system owners, to monitor and manage the solar PV system (iv) a residential storage and backup solution which includes a company designed and manufactured lithium-ion DC-coupled battery that is used to increase energy independence and maximize self-consumption for homeowners including a battery, and (v) additional smart energy management solutions.
|
b. |
The Company has expanded its activity to other areas of smart energy technology organically and through acquisitions. The Company now offers a variety of energy solutions, which include lithium-ion cells, batteries, and energy storage systems (“Energy Storage”), full powertrain kits for electric vehicles, or EVs (“e-Mobility”), as well as automated machines for industrial use (“Automation Machines”). |
c. |
Basis of Presentation:
|
d. |
Use of estimates:
|
F - 10
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
e. |
Concentrations of supply risks:
|
f. |
New accounting pronouncements not yet adopted:
|
g. |
Recently issued and adopted pronouncements:
|
F - 11
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
Amortized
cost |
Gross unrealized
gains
|
Gross unrealized
losses
|
Fair value
|
|||||||||||||
Available-for-sale – matures within one year:
|
||||||||||||||||
Corporate bonds
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
Governmental bonds
|
|
|
(
|
)
|
|
|||||||||||
|
|
(
|
)
|
|
||||||||||||
Available-for-sale – matures after one year:
|
||||||||||||||||
Corporate bonds
|
|
|
(
|
)
|
|
|||||||||||
Governmental bonds
|
|
|
(
|
)
|
|
|||||||||||
|
|
(
|
)
|
|
||||||||||||
Total
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
Amortized
cost |
Gross unrealized
gains
|
Gross unrealized
losses
|
Fair value
|
|||||||||||||
Available-for-sale – matures within one year:
|
||||||||||||||||
Corporate bonds
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
Governmental bonds
|
|
|
(
|
)
|
|
|||||||||||
|
|
(
|
)
|
|
||||||||||||
Available-for-sale – matures after one year:
|
||||||||||||||||
Corporate bonds
|
|
|
(
|
)
|
|
|||||||||||
Governmental bonds
|
|
|
(
|
)
|
|
|||||||||||
|
|
(
|
)
|
|
||||||||||||
Total
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
F - 12
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
September 30,
2022
|
December 31,
2021
|
|||||||
Raw materials
|
$
|
|
$
|
|
||||
Work in process
|
|
|
||||||
Finished goods
|
|
|
||||||
$
|
|
$
|
|
F - 13
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 5: DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
As of September 30, 2022, the Company entered into forward contracts and put and call options to sell U.S. dollars (“USD”) for NIS in the amount of approximately NIS
In addition to the above-mentioned cash flow hedge transactions, the Company also entered into derivative instrument arrangements to hedge the Company’s exposure to currencies other than the USD. These derivative instruments are not designated as cash flow hedges, as defined by ASC 815, and therefore all gains and losses, resulting from fair value remeasurement, were recorded immediately in the statement of income, under "Financial expense, net".
The Company classifies cash flows related to its hedging as operating activities in its condensed consolidated statement of cash flows.
As of September 30, 2022, the Company entered into forward contracts to sell Australian dollars (“AUD”) for USD in the amount of AUD
As of September 30, 2022, the Company entered into forward contracts to sell Euro for USD in the amount of €
The fair values of outstanding derivative instruments were as follows:
Balance sheet location
|
September 30,
2022
|
December 31,
2021
|
|||||||
Derivative assets of options and forward contracts:
|
|||||||||
Designated cash flow hedges
|
Prepaid expenses and other current assets
|
$
|
|
$
|
|
||||
Non-designated hedges
|
Prepaid expenses and other current assets
|
|
|
||||||
Total derivative assets
|
$
|
|
$
|
|
|||||
Derivative liabilities of options and forward contracts:
|
|||||||||
Designated cash flow hedges
|
Accrued expenses and other current liabilities
|
$
|
(
|
)
|
$
|
|
|||
Non-designated hedges
|
Accrued expenses and other current liabilities
|
|
(
|
)
|
|||||
Total derivative liabilities
|
$
|
(
|
)
|
$
|
(
|
)
|
F - 14
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
Gains (losses) on derivative instruments recognized in our income statements are summarized below:
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
Affected line item |
Foreign exchange contracts |
|
|
|
|
|
|
|
|
|
|
Non Designated Hedging Instruments |
|
$ |
|
$ |
|
$ |
|
$ |
|
Financial expenses, net |
See Note 13 for information regarding gains (losses) from designated hedging instruments reclassified from accumulated other comprehensive loss.
Gains (losses) on derivative instruments recognized in the consolidated comprehensive income (loss) statements were as follows:
|
Three Months Ended |
Nine Months Ended |
||||||||||||||
|
2022 |
2021 |
2022 |
2021 |
||||||||||||
Foreign exchange contracts: |
||||||||||||||||
Designated Hedging Instruments |
$ |
( |
) |
$ |
|
$ |
( |
) |
$ |
|
F - 15
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
Fair value measurements as of
|
||||||||||
Description
|
Fair Value
Hierarchy
|
September 30,
2022
|
December 31,
2021
|
|||||||
Assets:
|
||||||||||
Cash equivalents:
|
||||||||||
Cash
|
Level 1
|
$
|
|
$
|
|
|||||
Money market mutual funds
|
Level 1
|
$
|
|
$
|
|
|||||
Deposits
|
Level 1
|
$
|
|
$
|
|
|||||
Derivative instruments
|
Level 2
|
$
|
|
$
|
|
|||||
Short-term marketable securities:
|
||||||||||
Corporate bonds
|
Level 2
|
$
|
|
$
|
|
|||||
Governmental bonds
|
Level 2
|
$
|
|
$
|
|
|||||
Long-term marketable securities:
|
||||||||||
Corporate bonds
|
Level 2
|
$
|
|
$
|
|
|||||
Governmental bonds
|
Level 2
|
$
|
|
$
|
|
|||||
Liabilities:
|
||||||||||
Derivative instruments
|
Level 2
|
$
|
(
|
)
|
$
|
(
|
)
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
Balance, at the beginning of the period
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Additions and adjustments to cost of revenues
|
|
|
|
|
||||||||||||
Usage and current warranty expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
( |